Cancer Research UK Promoting Early Presentation Group, Institute of Psychiatry, Kings College London, St Thomas' Hospital, London SE1 7EH, UK.
Eur J Cancer. 2010 May;46(8):1374-81. doi: 10.1016/j.ejca.2010.02.034. Epub 2010 Mar 23.
Until now, there has been no universally accepted and validated measure of breast cancer awareness. This study aimed to validate the new Breast Cancer Awareness Measure (BCAM) which assesses, using a self-complete questionnaire, knowledge of breast cancer symptoms and age-related risk, and frequency of breast checking.
We measured the psychometric properties of the BCAM in 1035 women attending the NHS Breast Screening Programme: acceptability was assessed using a feedback questionnaire (n=292); sensitivity to change after an intervention promoting breast cancer awareness (n=576), and test-retest reliability (n=167). We also assessed readability, and construct validity using the 'known-groups' method.
The readability of the BCAM was high. Over 90% of women found it acceptable. The BCAM was sensitive to change: there was an increase in the proportion of women obtaining the full score for breast cancer awareness one month after receiving the intervention promoting breast cancer awareness; this was greater among those who received a more intensive version (less intensive version (booklet): 9.3%, 95% confidence interval (CI): 4.5-14.1%; more intensive version (interaction with health professional plus booklet): 30%, 95% CI: 23.4-36.6%). Test-retest reliability of the BCAM was moderate to good for most items. Cancer experts had higher levels of cancer awareness than non-medical academics (50% versus 6%, p=0.001), indicating good construct validity.
The BCAM is a valid and robust measure of breast cancer awareness suitable for use in surveys of breast cancer awareness in the general population and to evaluate the impact of awareness-raising interventions.
到目前为止,还没有一个被普遍接受和验证的乳腺癌意识衡量标准。本研究旨在验证新的乳腺癌意识测量工具(BCAM),该工具使用自我完成的问卷评估对乳腺癌症状和与年龄相关的风险以及乳房检查频率的了解。
我们在 NHS 乳房筛查计划中对 1035 名女性测量了 BCAM 的心理测量特性:使用反馈问卷(n=292)评估可接受性;干预后对乳腺癌意识的变化进行敏感性评估(n=576),并进行测试-重测可靠性评估(n=167)。我们还评估了可读性和使用“已知组”方法的结构有效性。
BCAM 的可读性很高。超过 90%的女性认为它是可以接受的。BCAM 对变化敏感:在接受提高乳腺癌意识的干预措施一个月后,获得乳腺癌意识满分的女性比例有所增加;在接受更密集版本干预的女性中,这种增加更为明显(不那么密集的版本(小册子):9.3%,95%置信区间(CI):4.5-14.1%;更密集的版本(与健康专业人员互动加小册子):30%,95%CI:23.4-36.6%)。BCAM 的测试-重测可靠性对于大多数项目来说都是中等至良好的。癌症专家的癌症意识水平高于非医学学者(50%比 6%,p=0.001),表明具有良好的结构有效性。
BCAM 是一种有效的、可靠的乳腺癌意识衡量标准,适用于一般人群中乳腺癌意识的调查以及评估提高意识干预措施的效果。